Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.
PV Testing is mainly used in Cervical Cancer Screening. Cervical Cancer Screening is the biggest application. The main suppliers of HPV testing in the market include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD and Seegene, Inc., Qiagen is the biggest supplier, in 2016 Qiagen revenue was about $ 194.13 million and in 2017 Qiagen revenue will be about $ 204.06 million.Global HPV testing market can be divided into two big markets: Europe and North America. North America is the largest HPV testing region, in 2016, North America HPV testing revenue was about $ 248.12 million in 2016, in 2017, USA HPV testing revenue will be about $ 270.49 million.
In 2018, the global Human Parainfluenza Viruses Diagnostics market size was 580 million US$ and it is expected to reach 1100 million US$ by the end of 2025, with a CAGR of 8.3% during 2019-2025.
This report focuses on the global Human Parainfluenza Viruses Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Parainfluenza Viruses Diagnostics development in United States, Europe and China.
The key players covered in this study
Market segment by Type, the product can be split into
Follow-up HPV Testing
Market segment by Application, split into
Cervical Cancer Screening
Vaginal Cancer Screening
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Human Parainfluenza Viruses Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Human Parainfluenza Viruses Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Human Parainfluenza Viruses Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.